Učitavanje...
Trial Watch: Adoptively transferred cells for anticancer immunotherapy
Immunotherapies aimed at strengthening immune effector responses against malignant cells are growing at exponential rates. Alongside, the impressive benefits obtained by patients with advanced melanoma who received adoptively transferred tumor-infiltrating lymphocytes (TILs) have encouraged the scie...
Spremljeno u:
| Izdano u: | Oncoimmunology |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5674950/ https://ncbi.nlm.nih.gov/pubmed/29147628 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1363139 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|